Search hospitals

>

Nebraska

>

Lincoln

Saint Elizabeth Regional Medical Center

Claim this profile

Lincoln, Nebraska 68510

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Pancreatic Cancer

194 reported clinical trials

3 medical researchers

Photo of Saint Elizabeth Regional Medical Center in LincolnPhoto of Saint Elizabeth Regional Medical Center in LincolnPhoto of Saint Elizabeth Regional Medical Center in Lincoln

Summary

Saint Elizabeth Regional Medical Center is a medical facility located in Lincoln, Nebraska. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Saint Elizabeth Regional Medical Center is involved with conducting 194 clinical trials across 374 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.

Area of expertise

1

Lung Cancer

Global Leader

Saint Elizabeth Regional Medical Center has run 32 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I
2

Breast Cancer

Global Leader

Saint Elizabeth Regional Medical Center has run 28 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Saint Elizabeth Regional Medical Center

Bladder Cancer

Lung Cancer

Breast Cancer

Prostate Cancer

Breast cancer

Esophageal cancer

Multiple Myeloma

Bladder Carcinoma

Testicular cancer

Gastric cancer

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint Elizabeth Regional Medical Center?